Assessing a structured report for cervical cancer staging
Multidisciplinary Assesssment of Structured Report for Cervical Cancer Staging
This study is testing a new way to organize information about cervical cancer staging to see if it helps doctors be more consistent and improve care for patients.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 30 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | Fondazione Policlinico Universitario Agostino Gemelli IRCCS Academic / other |
| Locations | 1 site (Rome) |
| Trial ID | NCT06260358 on ClinicalTrials.gov |
What this trial studies
This observational study aims to validate a structured report designed for cervical cancer staging based on the FIGO system. The structured report is expected to help standardize the application of FIGO staging, thereby reducing discrepancies in staging and enhancing patient care and outcomes. Clinician participation is believed to improve the quality of the report, potentially minimizing the need for discussions among multidisciplinary teams.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older with a confirmed diagnosis of cervical cancer at any stage.
Not a fit: Patients under 18, those with an uncertain diagnosis of cervical cancer, or those not meeting MRI protocol standards may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to more accurate and consistent staging of cervical cancer, ultimately improving treatment decisions and patient outcomes.
How similar studies have performed: While this approach is focused on validating a structured report, similar studies have shown that standardized reporting can improve clinical outcomes, suggesting potential success.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥18 years old; * Overt biopsy-proven diagnosis of cervical cancer, at any stage; * Signed written informed consent to personal data treatment for research purposes Exclusion Criteria: * Age \<18 years old; * Uncertain diagnosis of cervical cancer; * MRI scan not according the standard acquisition protocol (ESUR guidelines); * Patients candidate to non-standard treatments; * Refusal to sign the written informed consent to personal data treatment for research purposes
Where this trial is running
Rome
- Advanced Radiology Center — Rome, Italy (Recruiting)
Study contacts
- Principal investigator: Evis Sala, Prof — Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- Study coordinator: Russo Luca
- Email: luca.russo@unicatt.it
- Phone: +390630158637
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.